Ireland· IE-PA-EU/1/11/734/005-008
Edarbi 40 mg tablets
A angiotensin ii receptor blockers (arbs), plain product containing azilsartan medoxomil, registered in Ireland by Takeda Pharma A/S.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Azilsartan medoxomil
- Manufacturer
- Takeda Pharma A/S
- Country
- Ireland (IE)
- ATC code
- C09CA
- ATC class
- Angiotensin II receptor blockers (ARBs), plain
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/11/734/005-008
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Azilsartan medoxomil in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandEdarbiTakeda Pharma A/S
- SpainEDARBI 40 mg COMPRIMIDOSTakeda Pharma A/S
- SwedenEdarbi 40 mg TablettTakeda Pharma A/S
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Edarbi
- Liechtenstein · Edarbi
- Norway · Edarbi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2e15b264-d9d8-4aa9-98b5-05755230eff7 GET /v1/drugs/2e15b264-d9d8-4aa9-98b5-05755230eff7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"C09CA"
],
"strength": null,
"pa_number": "EU/1/11/734/005-008",
"substances": [
"Azilsartan medoxomil"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "07/12/2011",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about azilsartan medoxomil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.